Vincent Puard

Speaker Bio

Dr. Vincent Puard is the Co-founder and CEO of MAbSilico, a pioneer in AI-driven antibody discovery. He holds a Ph.D. in Biology from the University of Tours and INRAe, with early research focused on human biomarkers. During a Marie Curie fellowship at Avacta Life Sciences (UK), he learnt the lifecycle of therapeutic biomolecules and business development. Dr. Puard further refined his expertise in oncology and protein chip platforms at the Luxembourg Institute of Health and the Institut Curie.
By bridging the gap between high-level laboratory research and computational modeling, he identified critical market needs in antibody development. He has scaled MAbSilico by integrating rigorous scientific training with business acceleration programs. Today, he leads the charge in enhancing traditional "in vitro" trial-and-error with in silico AI solutions. In collaboration with partners like NVIDIA and Dell, he is accelerating the delivery of next-generation immunotherapies. His leadership is defined by a strategic vision for the intersection of high-performance computing and biotech.